Clinical trial
Comparative Study of the Efficacy of Treatment of Idiopathic Overactive Bladder (OAB) in Children: Oxybutynine vs. Transcutaneous Neurostimulation
NCT07030803 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire, Amiens as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparative Study of the Efficacy of Treatment of Idiopathic Overactive Bladder (OAB) in Children: Oxybutynine vs. Transcutaneous Neurostimulation
- Lead sponsor
- Centre Hospitalier Universitaire, Amiens
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 5, 2025
- Completion date
- March 31, 2029
- Enrollment
- 124 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
overactive bladder (oab), posterior tibial nerve stimulation, transcutaneous neurostimulation